Market research
SQD.V SQI Diagnostics Inc
V CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 6M
- P/E ratio
- Not available
- Analyst target
- 6
- Dividend yield
- Not available
- Beta
- -0.21
Profile
Company facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- CA78466B1085
- Market cap
- 6M
- P/E ratio
- Not available
- Analyst target
- 6
- Dividend yield
- Not available
- Beta
- -0.21
About
About SQI Diagnostics Inc
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SQD.V discussion.
5 years, 5 months ago
SQI Diagnostics Inc is currently in a long term downtrend where the price is trading 36.1% below its 200 day moving average.
From a valuation standpoint, the stock is 89.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 102.6.
SQI Diagnostics Inc's total revenue sank by 22.2% to $161K since the same quarter in the previous year.
Its net income has dropped by 84.6% to $-4M since the same quarter in the previous year.
Finally, its free cash flow grew by 27.4% to $-1M since the same quarter in the previous year.
Based on the above factors, SQI Diagnostics Inc gets an overall score of 2/5.